Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium.

Colonoscopy Colorectal cancer Epidemiology Incidence Lynch Syndrome Over-diagnosis Penetrance Prevention Prospective Segregation analysis

Journal

Hereditary cancer in clinical practice
ISSN: 1731-2302
Titre abrégé: Hered Cancer Clin Pract
Pays: Poland
ID NLM: 101231179

Informations de publication

Date de publication:
01 Oct 2022
Historique:
received: 03 12 2021
accepted: 31 08 2022
entrez: 1 10 2022
pubmed: 2 10 2022
medline: 2 10 2022
Statut: epublish

Résumé

To compare colorectal cancer (CRC) incidences in carriers of pathogenic variants of the MMR genes in the PLSD and IMRC cohorts, of which only the former included mandatory colonoscopy surveillance for all participants. CRC incidences were calculated in an intervention group comprising a cohort of confirmed carriers of pathogenic or likely pathogenic variants in mismatch repair genes (path_MMR) followed prospectively by the Prospective Lynch Syndrome Database (PLSD). All had colonoscopy surveillance, with polypectomy when polyps were identified. Comparison was made with a retrospective cohort reported by the International Mismatch Repair Consortium (IMRC). This comprised confirmed and inferred path_MMR carriers who were first- or second-degree relatives of Lynch syndrome probands. In the PLSD, 8,153 subjects had follow-up colonoscopy surveillance for a total of 67,604 years and 578 carriers had CRC diagnosed. Average cumulative incidences of CRC in path_MLH1 carriers at 70 years of age were 52% in males and 41% in females; for path_MSH2 50% and 39%; for path_MSH6 13% and 17% and for path_PMS2 11% and 8%. In contrast, in the IMRC cohort, corresponding cumulative incidences were 40% and 27%; 34% and 23%; 16% and 8% and 7% and 6%. Comparing just the European carriers in the two series gave similar findings. Numbers in the PLSD series did not allow comparisons of carriers from other continents separately. Cumulative incidences at 25 years were < 1% in all retrospective groups. Prospectively observed CRC incidences (PLSD) in path_MLH1 and path_MSH2 carriers undergoing colonoscopy surveillance and polypectomy were higher than in the retrospective (IMRC) series, and were not reduced in path_MSH6 carriers. These findings were the opposite to those expected. CRC point incidence before 50 years of age was reduced in path_PMS2 carriers subjected to colonoscopy, but not significantly so.

Identifiants

pubmed: 36182917
doi: 10.1186/s13053-022-00241-1
pii: 10.1186/s13053-022-00241-1
pmc: PMC9526951
doi:

Types de publication

Journal Article

Langues

eng

Pagination

36

Subventions

Organisme : NCI NIH HHS
ID : P30 CA071789
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Hered Cancer Clin Pract. 2019 Feb 28;17:8
pubmed: 30858900
Cancer Epidemiol Biomarkers Prev. 2019 Jun;28(6):1010-1014
pubmed: 30824524
JAMA. 2005 Nov 2;294(17):2195-202
pubmed: 16264161
Gastroenterology. 2008 Apr;134(4):988-97
pubmed: 18395080
Fam Cancer. 2020 Apr;19(2):169-175
pubmed: 31997046
Gastroenterology. 1995 May;108(5):1405-11
pubmed: 7729632
Gut. 2017 Sep;66(9):1657-1664
pubmed: 27261338
Br J Cancer. 2011 Jun 28;105(1):162-9
pubmed: 21559014
Br J Surg. 2021 May 27;108(5):484-498
pubmed: 34043773
Genet Med. 2021 Oct;23(10):1807-1817
pubmed: 34140662
Gastroenterology. 2018 Nov;155(5):1400-1409.e2
pubmed: 30063918
Hered Cancer Clin Pract. 2020 Mar 14;18:6
pubmed: 32190163
J Med Genet. 2007 Jun;44(6):353-62
pubmed: 17327285
J Clin Oncol. 2018 Oct 10;36(29):2961-2968
pubmed: 30161022
PLoS One. 2015 Mar 27;10(3):e0121980
pubmed: 25816162
Int J Cancer. 2018 Nov 1;143(9):2250-2260
pubmed: 29904935
Int J Cancer. 2021 Feb 15;148(4):800-811
pubmed: 32683684
Mod Pathol. 2018 Oct;31(10):1608-1618
pubmed: 29884888
Hered Cancer Clin Pract. 2019 Oct 14;17:28
pubmed: 31636762
Nat Med. 2020 Apr;26(4):566-576
pubmed: 32251400
Exp Mol Pathol. 2021 Oct;122:104668
pubmed: 34302852
Gut. 2013 Jun;62(6):812-23
pubmed: 23408351
Lancet Oncol. 2012 Jun;13(6):598-606
pubmed: 22552011
Lancet. 1995 May 6;345(8958):1183-4
pubmed: 7723574
Clin Cancer Res. 2020 Sep 1;26(17):4503-4510
pubmed: 32540851
Nat Med. 2020 Apr;26(4):475-484
pubmed: 32273608
Hered Cancer Clin Pract. 2017 Oct 10;15:18
pubmed: 29046738
Lancet Oncol. 2021 Jul;22(7):1014-1022
pubmed: 34111421
JAMA. 2011 Jun 8;305(22):2304-10
pubmed: 21642682
Gastroenterology. 2018 Sep;155(3):844-851
pubmed: 29758216

Auteurs

Pål Møller (P)

Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, 0379, Oslo, Norway. moller.pal@gmail.com.

Toni Seppälä (T)

Department of Gastrointestinal Surgery, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
Applied Tumour Genomics Research Program, University of Helsinki, Helsinki, Finland.
Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland.

James G Dowty (JG)

Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, 3010, Australia.

Saskia Haupt (S)

Engineering Mathematics and Computing Lab (EMCL), Interdisciplinary Center for Scientific Computing (IWR), Heidelberg University, Heidelberg, Germany.
Data Mining and Uncertainty Quantification (DMQ), Heidelberg Institute for Theoretical Studies (HITS), Heidelberg, Germany.

Mev Dominguez-Valentin (M)

Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, 0379, Oslo, Norway.

Lone Sunde (L)

Department of Clinical Genetics, Aalborg University Hospital, 9000, Aalborg, Denmark.
Department of Biomedicine, Aarhus University, DK-8000, Aarhus, Denmark.

Inge Bernstein (I)

Department of Surgical Gastroenterology, Aalborg University Hospital, Aalborg University, 9100, Aalborg, Denmark.
Institute of Clinical Medicine, Aalborg University Hospital, Aalborg University, 9100, Aalborg, Denmark.

Christoph Engel (C)

Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, 04107, Leipzig, Germany.

Stefan Aretz (S)

Institute of Human Genetics, National Center for Hereditary Tumor Syndromes, Medical Faculty, University of Bonn, 53127, Bonn, Germany.

Maartje Nielsen (M)

Department of Clinical Genetics, Leids Universitair Medisch Centrum, 2300RC, Leiden, The Netherlands.

Gabriel Capella (G)

Hereditary Cancer Program, Institut Català d'Oncologia-IDIBELL, L; Hospitalet de Llobregat, 08908, Barcelona, Spain.

Dafydd Gareth Evans (DG)

Division of Evolution and Genomic Sciences, Manchester Centre for Genomic Medicine, University of Manchester, Manchester University NHS Foundation Trust, Manchester, M13 9WL, UK.

John Burn (J)

Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE1 3BZ, UK.

Elke Holinski-Feder (E)

Campus Innenstadt, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, 80336, Munich, Germany.
MGZ - Center of Medical Genetics, 80335, Munich, Germany.

Lucio Bertario (L)

Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology, IRCCS, 20141, Milan, Italy.

Bernardo Bonanni (B)

Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology, IRCCS, 20141, Milan, Italy.

Annika Lindblom (A)

Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76, Stockholm, Sweden.

Zohar Levi (Z)

Department Rabin Medical Center, Service High Risk GI Cancer Gastroenterology, Petach Tikva, Israel.

Finlay Macrae (F)

Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Melbourne, Australia.
Department of Medicine, Melbourne University, Melbourne, Australia.

Ingrid Winship (I)

Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Melbourne, Australia.
Department of Medicine, Melbourne University, Melbourne, Australia.

John-Paul Plazzer (JP)

The Royal Melbourne Hospital, Melbourne, Australia.

Rolf Sijmons (R)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Luigi Laghi (L)

Department of Medicine and Surgery, Laboratory of Molecular Gastroenterology, IRCCS Humanitas Research Hospital, University of Parma, Parma, Italy.

Adriana Della Valle (AD)

Hospital Fuerzas Armadas, Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Montevideo, Uruguay.

Karl Heinimann (K)

Medical Genetics, Institute for Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.

Elizabeth Half (E)

Gastrointestinal Cancer Prevention Unit, Gastroenterology Department, Rambam Health Care Campus, Haifa, Israel.

Francisco Lopez-Koestner (F)

Programa Cáncer Heredo Familiar Clínica Universidad de los Ande, Santiago, Chile.

Karin Alvarez-Valenzuela (K)

Programa Cáncer Heredo Familiar Clínica Universidad de los Ande, Santiago, Chile.

Rodney J Scott (RJ)

University of Newcastle and the Hunter Medical Research Institute, Callaghan, Australia.

Lior Katz (L)

Department of Gastroenterology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Ido Laish (I)

The Department of Gastroenterology, High Risk and GI Cancer Prevention Clinic, Gastro-Oncology Unit, Sheba Medical Center, Ramat Gan, Israel.

Elez Vainer (E)

Department of Gastroenterology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Carlos Alberto Vaccaro (CA)

Hereditary Cancer Program (PROCANHE), Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina.

Dirce Maria Carraro (DM)

Genomic and Molecular Biology Group, A.C.Camargo Cancer Center, Sao Paulo, Brazil.

Nathan Gluck (N)

Department of Gastroenterology, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Naim Abu-Freha (N)

The Institute of Gastroenterology and Hepatology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Aine Stakelum (A)

St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.

Rory Kennelly (R)

St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.

Des Winter (D)

St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.

Benedito Mauro Rossi (BM)

Hospital Sirio Libanes, Sao Paulo, Brazil.

Marc Greenblatt (M)

University of Vermont, Larner College of Medicine, Burlington, VT, 05405, USA.

Mabel Bohorquez (M)

University of Tolima, Tolima, Colombia.

Harsh Sheth (H)

Foundation for Research in Genetics and Endocrinology, FRIGE House, Jodhpur Village Road, Satellite Ahmedabad, Ahmedabad, 380015, India.

Maria Grazia Tibiletti (MG)

Ospedale di Circolo ASST Settelaghi, Centro di Ricerca Tumori Eredo-Familiari, Università dell'Insubria, Varese, Italy.

Leonardo S Lino-Silva (LS)

Instituto Nacional de Cancerologia, Mexico, DF, Mexico.

Karoline Horisberger (K)

Department of Abdominal and Transplantation Surgery, Universitätsspital Zürich, Rämistrasse 100, CH-8091, Zürich, Switzerland.

Carmen Portenkirchner (C)

Department of Abdominal and Transplantation Surgery, Universitätsspital Zürich, Rämistrasse 100, CH-8091, Zürich, Switzerland.

Ivana Nascimento (I)

Laboratório de Imonologia, ICS/UFBA, Núcleo de Oncologia da Bahia/Oncoclinicas, Salvador, Brazil.

Norma Teresa Rossi (NT)

Hospital Privado Universitario de Córdoba, Cordoba, Argentina.

Leandro Apolinário da Silva (LA)

Hospital Universitario Oswaldo Cruz, Universidade de Pernambuco, Hospital de Câncer de Pernambuco, IPON - Instituto de Pesquisas Oncológicas do Nordeste, Salvador, Brazil.

Huw Thomas (H)

Department of Surgery and Cancer, St Mark's Hospital, Imperial College London, London, UK.

Attila Zaránd (A)

Department of Transplantation and Surgery, Semmelweis University Budapest, Budapest, Hungary.

Jukka-Pekka Mecklin (JP)

Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland.
Department of Surgery, Central Finland Health Care District, Jyväskylä, Finland.

Kirsi Pylvänäinen (K)

Department of Education and Science, Central Finland Health Care District, Jyväskylä, Finland.

Laura Renkonen-Sinisalo (L)

Department of Gastrointestinal Surgery, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
Applied Tumour Genomics Research Program, University of Helsinki, Helsinki, Finland.

Anna Lepisto (A)

Department of Gastrointestinal Surgery, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
Applied Tumour Genomics Research Program, University of Helsinki, Helsinki, Finland.

Päivi Peltomäki (P)

Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.

Christina Therkildsen (C)

The Danish HNPCC Register, Gastro Unit, Copenhagen University Hospital - Amager and Hvidovre, Copenhagen, Denmark.

Lars Joachim Lindberg (LJ)

The Danish HNPCC Register, Gastro Unit, Copenhagen University Hospital - Amager and Hvidovre, Copenhagen, Denmark.

Ole Thorlacius-Ussing (O)

Department of Surgical Gastroenterology, Aalborg University Hospital, Aalborg University, 9100, Aalborg, Denmark.
Institute of Clinical Medicine, Aalborg University Hospital, Aalborg University, 9100, Aalborg, Denmark.

Magnus von Knebel Doeberitz (M)

Department of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Clinical Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Markus Loeffler (M)

Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.

Nils Rahner (N)

Institute of Human Genetics, University Clinic Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.

Verena Steinke-Lange (V)

Campus Innenstadt, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, 80336, Munich, Germany.
MGZ - Center of Medical Genetics, 80335, Munich, Germany.

Wolff Schmiegel (W)

Department of Medicine, Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany.

Deepak Vangala (D)

Department of Medicine, Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany.

Claudia Perne (C)

Institute of Human Genetics, National Center for Hereditary Tumor Syndromes, Medical Faculty, University of Bonn, 53127, Bonn, Germany.

Robert Hüneburg (R)

Department of Internal Medicine, University Hospital Bonn, Bonn, Germany.

Aída Falcón de Vargas (AF)

Genetics Unit, Hospital Vargas de Caracas, Caracas, Venezuela.
Escuela de Medicina Jose Maria Vargas, Universidad, Central de Venezuela, UCV, Caracas, Venezuela.

Andrew Latchford (A)

St Mark's Hospital, London, UK.

Anne-Marie Gerdes (AM)

Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, DK-2100, Copenhagen, Denmark.

Ann-Sofie Backman (AS)

Department of Medicine Solna, Unit of Internal medicine, Karolinska Institutet, Stockholm, Sweden.

Carmen Guillén-Ponce (C)

Medical Oncology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.

Carrie Snyder (C)

Hereditary Cancer Center, Department of Preventive Medicine, Creighton University, Omaha, NE, 68178, USA.

Charlotte K Lautrup (CK)

Department of Clinical Genetics, Aalborg University Hospital, 9000, Aalborg, Denmark.

David Amor (D)

Murdoch Children's Research Institute and University of Melbourne Department of Paediatrics, Royal Children's Hospital, Parkville, VIC, 3052, Australia.

Edenir Palmero (E)

Department of Genetics, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.

Elena Stoffel (E)

Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

Floor Duijkers (F)

Department of Clinical Genetics, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands.

Michael J Hall (MJ)

Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.

Heather Hampel (H)

Division of Human Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA.

Heinric Williams (H)

Department of Urology, Geisinger Medical Center, Danville, PA, 17822, USA.

Henrik Okkels (H)

Department of Molecular Diagnostics, Aalborg University, Aalborg, Denmark.

Jan Lubiński (J)

Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.

Jeanette Reece (J)

Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, 3010, Australia.

Joanne Ngeow (J)

Lee Kong Chian School of Medicine, Nanyang Technological University Singapore and Cancer Genetics Service National Cancer Centre Singapore, Singapore, Singapore.

Jose G Guillem (JG)

Gastrointestinal Surgery, University of North Carolina, Chapel Hill, NC, USA.

Julie Arnold (J)

New Zealand Familial Gastrointestinal Cancer Service, Auckland, New Zealand.

Karin Wadt (K)

Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, DK-2100, Copenhagen, Denmark.

Kevin Monahan (K)

St Mark's Hospital & Imperial College, London, UK.

Leigha Senter (L)

Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA.

Lene J Rasmussen (LJ)

Department of Cellular and Molecular Medicine, Center for Healthy Aging, University of Copenhagen, Copenhagen, Denmark.

Liselotte P van Hest (LP)

Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.

Luigi Ricciardiello (L)

IRCCS AOU di Bologna, and Department of Medical and Surgical Sciences - University of Bologna, Bologna, Italy.

Maija R J Kohonen-Corish (MRJ)

Woolcock Institute of Medical Research, Glebe, Sydney, NSW, 2037, Australia.

Marjolijn J L Ligtenberg (MJL)

Department of Human Genetics and Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.

Melissa Southey (M)

Monash Health Translation Precinct, Monash University, Clayton South, VIC, 3169, Australia.

Melyssa Aronson (M)

Zane Cohen Centre, Sinai Health System, Toronto, Ontario, Canada.

Mohd N Zahary (MN)

Faculty of Health Sciences, University Sultan Zainal Abidin, Kuala Terengganu, Terengganu, Malaysia.

N Jewel Samadder (NJ)

Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ, 85054, USA.

Nicola Poplawski (N)

Adelaide Medical School, University of Adelaide, Adelaide, SA, 5000, Australia.
Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, SA, 5000, Australia.

Nicoline Hoogerbrugge (N)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Patrick J Morrison (PJ)

Regional Medical Genetics Centre, Belfast HSC Trust, City Hospital Campus, Queen's University Belfast, Belfast, Northern Ireland, UK.

Paul James (P)

Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, 3010, Australia.

Grant Lee (G)

Genomics Platform Group, Centre for Cancer Research, University of Melbourne, Parkville, VIC, Australia.

Rakefet Chen-Shtoyerman (R)

The Biology Department, Ariel University, Ariel and the Oncogenetic Clinic, The Clinical Genetics Institute, Kaplan Medical Center, Rehovot, Israel.

Ravindran Ankathil (R)

Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.

Rish Pai (R)

Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, AZ, 85259, USA.

Robyn Ward (R)

Faculty of Medicine and Health, University of Sydney, Sydney, NSW, 2006, Australia.

Susan Parry (S)

New Zealand Familial Gastrointestinal Cancer Service, Auckland, New Zealand.

Tadeusz Dębniak (T)

Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland.

Thomas John (T)

Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Thomas van Overeem Hansen (T)

Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, DK-2100, Copenhagen, Denmark.

Trinidad Caldés (T)

Molecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.

Tatsuro Yamaguchi (T)

Department of Clinical Genetics, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.

Verónica Barca-Tierno (V)

Department of Genetics, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.

Pilar Garre (P)

Molecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.

Giulia Martina Cavestro (GM)

Gastroenterology and Gastrointestinal Endoscopy Unit, Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy.

Jürgen Weitz (J)

Technische Universität Dresden, Dresden, Germany.

Silke Redler (S)

Institute of Human Genetics, University Clinic Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.

Reinhard Büttner (R)

Department of Pathology, University Hospital of Cologne, Cologne, Germany.

Vincent Heuveline (V)

Engineering Mathematics and Computing Lab (EMCL), Interdisciplinary Center for Scientific Computing (IWR), Heidelberg University, Heidelberg, Germany.

John L Hopper (JL)

Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, 3010, Australia.

Aung Ko Win (AK)

Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, 3010, Australia.

Noralane Lindor (N)

Department of Health Science Research, Mayo Clinic Arizona, Phoenix, USA.

Steven Gallinger (S)

Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada.

Loïc Le Marchand (L)

University of Hawaii Cancer Center, Honolulu, USA.

Polly A Newcomb (PA)

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109-1024, USA.

Jane Figueiredo (J)

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109-1024, USA.

Daniel D Buchanan (DD)

Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia.
University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia.
Genomic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Stephen N Thibodeau (SN)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.

Sanne W Ten Broeke (SW)

Leids Universitair Medisch Centrum, Leiden, Netherlands.

Eivind Hovig (E)

Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, 0379, Oslo, Norway.
Department of Informatics, Centre for Bioinformatics, University of Oslo, Oslo, Norway.

Sigve Nakken (S)

Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, 0379, Oslo, Norway.
Centre for Cancer Cell Reprogramming (CanCell), Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Marta Pineda (M)

Hereditary Cancer Program, Institut Català d'Oncologia-IDIBELL, L; Hospitalet de Llobregat, 08908, Barcelona, Spain.

Nuria Dueñas (N)

Hereditary Cancer Program, Institut Català d'Oncologia-IDIBELL, L; Hospitalet de Llobregat, 08908, Barcelona, Spain.

Joan Brunet (J)

Hereditary Cancer Program, Institut Català d'Oncologia-IDIBELL, L; Hospitalet de Llobregat, 08908, Barcelona, Spain.

Kate Green (K)

Division of Evolution and Genomic Sciences, Manchester Centre for Genomic Medicine, University of Manchester, Manchester University NHS Foundation Trust, Manchester, M13 9WL, UK.

Fiona Lalloo (F)

Division of Evolution and Genomic Sciences, Manchester Centre for Genomic Medicine, University of Manchester, Manchester University NHS Foundation Trust, Manchester, M13 9WL, UK.

Katie Newton (K)

Department of Surgery, Central Manchester University Hospitals NHS Foundation Trust and University of Manchester, Manchester, UK.

Emma J Crosbie (EJ)

Gynaecological Oncology Research Group, Manchester University NHS Foundation Trust, Manchester, UK.
Division of Cancer Sciences, University of Manchester, Manchester, UK.

Miriam Mints (M)

Division of Obstetrics and Gyneacology, Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden.

Douglas Tjandra (D)

Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Melbourne, Australia.
Department of Medicine, Melbourne University, Melbourne, Australia.

Florencia Neffa (F)

Hospital Fuerzas Armadas, Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Montevideo, Uruguay.

Patricia Esperon (P)

Hospital Fuerzas Armadas, Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Montevideo, Uruguay.

Revital Kariv (R)

Department of Gastroenterology, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Guy Rosner (G)

Department of Gastroenterology, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Walter Hernán Pavicic (WH)

Hereditary Cancer Program (PROCANHE), Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina.
Instituto de Medicina Traslacional e Ingeniería Biomédica (IMTIB), Hospital Italiano de Buenos Aires-IUHI-CONICET, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina.

Pablo Kalfayan (P)

Hereditary Cancer Program (PROCANHE), Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina.

Giovana Tardin Torrezan (GT)

Genomic and Molecular Biology Group, A.C.Camargo Cancer Center, Sao Paulo, Brazil.

Thiago Bassaneze (T)

Hospital Sirio Libanes, Sao Paulo, Brazil.

Claudia Martin (C)

Hospital Universitario Oswaldo Cruz, Universidade de Pernambuco, Hospital de Câncer de Pernambuco, IPON - Instituto de Pesquisas Oncológicas do Nordeste, Salvador, Brazil.

Gabriela Moslein (G)

Surgical Center for Hereditary Tumors, Ev. Bethesda Khs Duisburg, University Witten-Herdecke, Herdecke, Germany.

Aysel Ahadova (A)

Department of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.

Matthias Kloor (M)

Department of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.

Julian R Sampson (JR)

Division of Cancer and Genetics, Institute of Medical Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK.

Mark A Jenkins (MA)

Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, 3010, Australia.

Classifications MeSH